Promyelocytic Leukemia Protein (PML) Requirement for Interferon-induced Global Cellular SUMOylation.

Maroui, Mohamed Ali; Maarifi, Ghizlane; McManus, Francis P; Lamoliatte, Frédéric; Thibault, Pierre; Chelbi-Alix, Mounira K

Maroui, Mohamed Ali; Maarifi, Ghizlane; McManus, Francis P; Lamoliatte, Frédéric; Thibault, Pierre; Chelbi-Alix, Mounira K.

Affiliation

Maroui MA; From the INSERM UMR-S1124, 75006 Paris, France.
Maarifi G; §Université Paris Descartes, 75006 Paris, France.
McManus FP; From the INSERM UMR-S1124, 75006 Paris, France.
Lamoliatte F; §Université Paris Descartes, 75006 Paris, France.
Thibault P; ¶Institute for Research in Immunology and Cancer, H3T 1J4, Québec, Canada.
Chelbi-Alix MK; ¶Institute for Research in Immunology and Cancer, H3T 1J4, Québec, Canada.

Mol Cell Proteomics ; 17(6): 1196-1208, 2018 06.

Article in En | MEDLINE | ID: mdl-29535160

Subject(s)

Interferon-alpha/pharmacology; Promyelocytic Leukemia Protein/metabolism; Sumoylation/drug effects; HEK293 Cells; Humans

Key words

Cytokines*; Interferon; Mass Spectrometry; PML; Post-translational modifications*; SUMO; Systems biology*; Tandem Mass Spectrometry; UBC9; Ubiquitinases

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Interferon-alpha / Sumoylation / Promyelocytic Leukemia Protein Limits: Humans Language: En Journal: Mol Cell Proteomics Journal subject: BIOLOGIA MOLECULAR / BIOQUIMICA Year: 2018 Type: Article Affiliation country: France

Fulltext

XML

PubMed Links

Search on Google